| 摘要 |
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, (Formula (I)) wherein R1a, R1b, R1c, X, Y, Z, n, and m are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as Cdc7 and methods of treating diseases such as cancer.
|
